AST-301,a pDNA-based cancer vaccine encoding HER2-ICD, enhances anti-tumor effect of HER2-ADC in a HER2-expressed gastric cancer xenograft model

被引：0
|
作者：
Kang, Jinho
Park, Hyo-Hyun
Choi, Jee Hyun
Lim, Jinback
Jang, Seong-Yong
Kim, Min-Ah
Park, Myeong-Kyu
Park, Yun-Hee
Lim, Soyeon
Chung, Chul-Woong
Choi, Jin Kyeong
Joung, Eunkyo
Kim, Ashley Yongmin
Jung, Hun
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4113
引用
收藏
页数：3
相关论文
共 32 条
  • [1] THE ANTI-TUMOR ACTIVITY OF HER-2/NEU ICD THERAPEUTIC CANCER VACCINE (AST-301, PNGVL3-HICD) IN HER2-EXPRESSED GASTRIC CANCER XENOGRAFT MODEL
    Jo, Gyeong Seok
    Joung, Eunkyo
    Shin, Jung Hyu
    Lee, Hye Lim
    Lim, Jinback
    Kim, Yoonyi
    Park, Hyo-Hyun
    Shin, Hunwoo
    Jung, Hun
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A811 - A811
  • [2] AST-301, a pDNAbased therapeutic cancer vaccine encoding HER2 ICD, improves the efficacy of checkpoint blockade therapy in CD34+humanized gastric cancer mouse model
    Park, Hyo-Hyun
    Kim, Hye-Ran
    Choi, Jin Kyeong
    Choi, Jee Hyun
    Kang, Jinho
    Lim, Jinback
    Lim, Hyo Jung
    Lee, Jong Yeong
    Joung, Eunkyo
    Jung, Hun
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [3] A phase I study of a DNA plasmid based vaccine encoding the HER2/neu (HER2) intracellular domain (ICD) in subjects with HER2+breast cancer
    Salazar, L. G.
    Slota, M.
    Wallace, D.
    Higgins, D.
    Coveler, A. L.
    Dang, Y.
    Childs, J.
    Bates, N.
    Waisman, J.
    Disis, M. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model
    Matsui, Y
    Inomata, M
    Tojigamori, M
    Sonoda, K
    Shiraishi, N
    Kitano, S
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (03) : 681 - 685
  • [5] Anti-tumor effect of Dasatinib in HER2 positive breast cancer with Trastuzumab resistance
    Takeda, Tatsuaki
    Kanzaki, Hirotaka
    Toyooka, Shinichi
    Watanabe, Mototsugu
    Ohtsuka, Tomoaki
    Suzawa, Ken
    Hashida, Shinsuke
    Maki, Yuho
    Yamamoto, Hiromasa
    Soh, Junichi
    Asano, Hiroaki
    Tsukuda, Kazunori
    Miyoshi, Shinichiro
    Kitamura, Yoshihisa
    Sendo, Toshiaki
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
    Ogoshi, Yusuke
    Shien, Kazuhiko
    Yoshioka, Takahiro
    Torigoe, Hidejiro
    Sato, Hiroki
    Sakaguchi, Masakiyo
    Tomida, Shuta
    Namba, Kei
    Kurihara, Eisuke
    Takahashi, Yuta
    Suzawa, Ken
    Yamamoto, Hiromasa
    Soh, Junichi
    Toyooka, Shinichi
    [J]. ONCOLOGY LETTERS, 2019, 17 (03) : 2729 - 2736
  • [7] Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device
    Galletti, Giuseppe
    Sung, Matthew S.
    Vahdat, Linda T.
    Shah, Manish A.
    Santana, Steven M.
    Altavilla, Giuseppe
    Kirby, Brian J.
    Giannakakou, Paraskevi
    [J]. LAB ON A CHIP, 2014, 14 (01) : 147 - 156
  • [8] Enhanced anti-tumor effect of trastuzumab combined with less cardiotoxic anthracycline, amrubicin, in a HER2-positive human cancer xenograft in athymic mice
    Tokuda, Y.
    Umemura, S.
    Saito, Y.
    Suzuki, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] ITRACONAZOLE EXERTS ITS ANTI-TUMOR EFFECT IN ESOPHAGEAL CANCER BY SUPPRESSING THE HER2/AKT SIGNALING PATHWAY
    Zhang, Wei
    Bhagwath, Ankur
    Williams, Taylor A.
    Subramaniyan, Indhumathy
    Edpuganti, Vindhya
    Kallem, Raja
    Gong, Ke
    Geurkink, Samuel
    Kim, James
    Zhang, Qiuyang
    Habib, Amyn
    Dowell, Jonathan
    Jie, Chunfa
    Putnam, William C.
    Pham, Thai
    Wang, David H.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S661 - S661
  • [10] ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer
    Barok, Mark
    Le Joncour, Vadim
    Martins, Ana
    Isola, Jorma
    Salmikangas, Marko
    Laakkonen, Pirjo
    Joensuu, Heikki
    [J]. CANCER LETTERS, 2020, 473 : 156 - 163
1234